Pistoia Alliance, a not-for-profit consortium of pharmaceutical companies, launched the
Sequence Services Phase 2 project, seeking a platform for analyzing and storing next-generation sequencing (NGS) data. We were selected from more than 10 submitted proposals, and, working together with Constellation Technologies, a spinout from Rutherford Appleton Laboratory, presented our platform at the Pistoia Alliance meeting in Boston in April 2012.